Fate Therapeutics (FATE) Shares Outstanding (2012 - 2026)
Fate Therapeutics (FATE) Shares Outstanding (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | Fate Therapeutics | 288.82 Mn | 288.82 Mn | - | 120.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 120.03 Mn |
| Dec 31, 2025 | 118.79 Mn |
| Sep 30, 2025 | 119.00 Mn |
| Jun 30, 2025 | 118.53 Mn |
| Mar 31, 2025 | 118.38 Mn |
| Dec 31, 2024 | 113.69 Mn |
| Sep 30, 2024 | 117.77 Mn |
| Jun 30, 2024 | 117.47 Mn |
| Mar 31, 2024 | 101.10 Mn |
| Dec 31, 2023 | 98.41 Mn |
| Sep 30, 2023 | 98.57 Mn |
| Jun 30, 2023 | 98.40 Mn |
| Mar 31, 2023 | 98.05 Mn |
| Dec 31, 2022 | 96.83 Mn |
| Sep 30, 2022 | 97.02 Mn |
| Jun 30, 2022 | 96.70 Mn |
| Mar 31, 2022 | 96.34 Mn |
| Dec 31, 2021 | 94.75 Mn |
| Sep 30, 2021 | 95.41 Mn |
| Jun 30, 2021 | 94.33 Mn |